GM law 'a blow for science'

German researchers and industry decry a new crop law as being detrimental to innovation

Written byNed Stafford
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The final passage of a highly restrictive genetically modified (GM) crops law is being hailed as a major victory by German Agriculture Minister Renate Künast, but the bioscience community and biotech sector see the new legislation as a blow to German science and industry.

Among the most controversial aspects of the new law are clauses holding planters of GM crops liable for economic damages to adjacent non-GM fields even if they followed planting instructions and other regulations. Opponents say this will create a financial risk some German universities, research organizations, and companies will not take.

Mark Stitt, managing director at the Max Planck Institute of Molecular Plant Physiology, told The Scientist: "I think the law, as it now stands, is going to have a very detrimental effect on innovation in Germany."

"Germany has potentially one of the most flourishing bioscience industries in the world," Stitt said. "But now, research will ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform